MedTrace Logo

Transcatheter Aortic Valve Replacement for Failed Transcatheter Aortic Valve

NCT04500964 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 173

Last updated 2023-10-17

No results posted yet for this study

Summary

Patients with failed transcather aortic valve (stenotic, regurgitant, both) and indication to further transcatheter aortic valve replacement (TAVR).

The purpouse of this study is to evaluate the indication to a second TAVR, the selection criteria of the second transcatheter aortic valve, procedural and clinical outcomes.

The primary endpoint of the study is overall mortality and Cardiovascular mortality at 1 year

Conditions

  • Failed Transcather Aortic Valve

Interventions

DEVICE

TAVR

Trancatheter aortic valve replacement

Sponsors & Collaborators

  • IRCCS Policlinico S. Donato

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-01-01
Primary Completion
2020-01-01
Completion
2020-07-01
FDA Device
Yes

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04500964 on ClinicalTrials.gov